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Objectives: To describe and critique a systematic multidisciplinary approach to user
engagement, and selection and evaluation of sensor technologies for development of
a sensor-based Digital Toolkit for assessment of movement in children with cerebral
palsy (CP).
Methods: A sequential process was employed comprising three steps: Step 1: define
user requirements, by identifying domains of interest; Step 2: map domains of interest to
potential sensor technologies; and Step 3: evaluate and select appropriate sensors to be
incorporated into the Digital Toolkit. The process employed a combination of principles
from frameworks based in either healthcare or technology design.
Results: A broad range of domains were ranked as important by clinicians, patients and
families, and industry users. These directly informed the device selection and evaluation
process that resulted in three sensor-based technologies being agreed for inclusion in
the Digital Toolkit, for use in a future research study.
Conclusion: This report demonstrates a systematic approach to user engagement
and device selection and evaluation during the development of a sensor-based
solution to a healthcare problem. It also provides a narrative on the benefits of
employing a multidisciplinary approach throughout the process. This work uses previous
frameworks for evaluating sensor technologies and expands on the methods used for
user engagement.
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OVERVIEW
Digital health technologies represent a new means of addressing modern healthcare challenges (1).
For example, wearable sensor technologies can generate in-depth physiological and performance
measurements outside of the laboratory environment, thereby, providing insight into real-world
user behaviours. This can help patients and clinicians evaluate therapies and monitor progress
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over time. When thoughtfully developed and implemented,
digital solutions can augment the role of the health care
professional and enhance patient participation in health
care decisions.
The following report describes a systematic multidisciplinary
approach to user engagement, and selection and evaluation of
sensor technologies for development of a sensor-based Digital
Toolkit for assessment of movement in children with cerebral
palsy (CP).
BACKGROUND
Cerebral palsy (CP) is a neurodevelopmental condition caused
by injury to the developing brain. It is the most frequent cause
of physical disability among children and has a life-long impact
on the individual and their use of healthcare (2, 3). People with
CP experience disordered posture and movement that in turn
causes limitations in activities (e.g., walking) (4, 5). This can lead
to physical inactivity, increased risk of developing cardiovascular
disease, and limited participation and social integration in the
home and community (3, 6, 7).
Rehabilitative and assistive devices, such as mobility and
postural aids, can help restore or replace the loss of activity
caused by a disability such as CP (8). However, a large
proportion of interventions for children with CP have low
or inconclusive evidence supporting their effectiveness (9, 10).
As assistive devices (such as wheelchairs, walking frames, and
communication devices) form a large part of standard care
for children with CP, a systematic, objective, and disciplined
approach to measuring clinical outcome is needed when
prescribing them (10). To date, specialised equipment and
technology have been vastly under-researched. This is potentially
due to benefits, such as independent mobility, being easily
observable yet difficult to objectively quantify outside of the
clinic or laboratory environment. Some simple clinical tests
allow for a quick overview of a patient’s condition, but do not
afford more in-depth evaluation of individual impairments or
components of activities that may, or may not, be amenable
to change. Nevertheless, considering device abandonment issues
and associated costs, extensive efficacy research is warranted at
both an individual and a population level. Moreover, prescribing
assistive technology may raise expectations of good outcomes by
the patient and family and give rise to an overinflated perception
of high-quality expert care. Thus, it is essential to know if
the interventions are working, to prevent device abandonment,
false hopes, and unnecessary effort (10). In addition, The Royal
Academy of Engineering has called for improved methodologies
to obtain evidence for not only safety and performance ofmedical
devices but also for efficacy (11).
To this end, a Digital Toolkit of sensor-based technologies
is currently being developed for assessment of movement in
children with CP, in relation to rehabilitative and assistive
devices. The Digital Toolkit will provide a means of integrating
and visualising data from commercially available, wearable
sensors to provide a platform for data-driven real-world
evaluation of effect of physical therapies, and rehabilitative and
assistive devices. To meet the needs of users and provide valuable
insights, a process of user engagement and device evaluation has
been used to inform the development of the Digital Toolkit.
Engagement with users (e.g., industry, clinicians, patients,
and families) throughout the technology development pipeline is
essential in ensuring that a product that adds significant value is
translated into practice and ultimately delivers impact (12, 13).
There is no universally accepted framework for engaging with
users in the development of digital health technologies. However,
in health and social care research in the UK, meaningful
involvement of users through Patient, and Public Involvement
(PPI) has increased in recent years and is now well-established
(14, 15). From a technology perspective, two research groups
have recently proposed processes for user engagement and
technology selection and evaluation (12, 16). Further to this,
there are established principles for user-centred design [ISO
9241-210:2019(en)], however, these tend to focus on how a user
engages with computer-based technology and have limited value
in guiding selection of sensors for digital health (17).
It is good practice to disseminate and critically reflect on the
approaches used for user engagement in healthcare. Principles
of the Short Form Guidance for Reporting Involvement of
Patients and the Public checklist (GRIPP2), developed to improve
reporting of patient and public involvement (PPI) in research,
have been embedded across this report (18).
The aim of this report is to document and critique a systematic
multidisciplinary approach to user engagement, and selection
and evaluation of sensor technologies for development of a
sensor-based Digital Toolkit for assessment of movement in
children with cerebral palsy (CP).
MATERIALS AND METHODS
A sequential process was employed comprising three steps:
Step 1: Define user requirements, by identifying domains
of interest;
Step 2: Map domains of interest to potential sensor
technologies; and
Step 3: Evaluate and select appropriate sensors to be
incorporated into the Digital Toolkit.
The process employed a combination of principles from
frameworks based in either healthcare or technology design (12,
14, 16).
Scope of the project: Inform the development of a Digital
Toolkit to aid in-depth objective evaluation of effectiveness of
mobility devices in children with CP.
Step 1: Define User Requirements
1a. Identification of Potential Domains of Interest
The Core Set for CP, derived from the World Health
Organisation’s International Classification of Functioning,
Disability and Health Children and Youth Version - ICF-
CY (WHO 2007), was used to identify potential domains of
interest to target with sensor technologies (19, 20). The ICF-CY
is a framework for describing and organising information
on functioning and disability. The framework covers body
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structures (anatomical parts of the body such as organs, limbs
and their components) and functions (physiological functions of
body systems), and activity (the execution of a task or action by
an individual) and participation (involvement in a life situation).
The Core Set for CP is a list of 135 ICF-CY domains that are
considered most important for describing the functional profile
of individuals with CP aged 0 to 18 years. Through discussion,
the research team compiled a short-list of domains from the
Core Set which were of potential relevance to the Digital
Toolkit (Table 1). Whilst the aim of the Digital Toolkit is to
aid assessment of movement in children with CP in relation to
rehabilitative and assistive devices, it was agreed that the current
project would focus on mobility devices. Selection criteria were
based on the research team’s consideration of the potential of the
ICF-CY domain to either:
a) demonstrate an immediate change, i.e., a change that may be
observed during use of a mobility device;
b) demonstrate a change in response to sustained use, i.e., a
change that may be observed when the device is used as part
of a training program over a period of time; or
c) domains that may have a bearing on the child’s ability to use a
mobility device.
The short-listed domains and their ICF-CY standard definitions
were compiled. To aid communication with non-clinical users,
“lay” definitions were developed by the research team.
1b. Rapid Review
A list of outcome measures reported as being used in children
with CP and relevant to each ICF-CY short-listed domain, was
generated through a series of rapid literature reviews. Each review
used key words elicited from the ICF-CY domain definitions.
Medline and Embase were searched from inception using key
words specific to each domain. For example, for the domain
“B455 Exercise Tolerance Functions” the following key terms
were used: (“exercise tolerance” OR “respiratory capacity” OR
“cardiovascular capacity” OR “physical endurance” OR “aerobic
capacity” OR “stamina” OR “fatigability” OR “fitness” OR
“exercise test” OR “cardiorespiratory” OR “cardiopulmonary”)
AND “cerebral palsy.”
A matrix was produced detailing included ICF-CY domains
(code, category name, sub-domains, standard definitions),
measurement instruments used in clinical practice or research
in CP for each domain, any reported technological/sensor-
based measurement solutions, references to relevant literature on
clinimetric properties, and links to websites where instruments
could be obtained.
1c. User Engagement
The domains and their associated definitions, short-listed in
Step 1a, were presented in separate deliberative workshops to
three stakeholder groups (21). The stakeholder groups were:
(i) children with CP and their families; (ii) clinicians; and (iii)
industry. The workshops were facilitated by both the clinical and
computer science researchers. The team adhered to the principles
of patient and public involvement (PPI) as proposed by NIHR
(14). The aim of the workshops was to obtain a broad range of
perspectives from end-users on the relative importance of the
short-listed domains.
Workshops With Children and Families
Two deliberative workshops were held with families of children
with CP. Workshops were advertised via social media (Twitter
and Facebook) and using two community mailing lists (Northern
Ireland Cerebral Palsy Register Community Mailing List, James
Leckey Design Families Communications Email List). Two
workshops were convened at a central location with accessible
parking at different times (one afternoon, one evening) in an
effort to accommodate work, childcare, and access arrangements.
Travel expenses of workshop participants were reimbursed and a
gift card to the value of £20 was provided in acknowledgement of
their time and contributions.
At each workshop the research team explained the project
to attendees: an overview of the short-listed domains and rapid
review (described above in Steps 1a and 1b) was presented
and a video demonstration of a range of potential sensors was
shown. Following group discussion, each adult was provided
with printed copies of the short-listed domains and their lay
definitions and was asked to rank order the domains from most
(ranked 1) to least important, in their opinion, with respect to
measuring the effects of mobility devices. Discussions were not
audio-recorded but researchers took anonymised notes during
the workshop. Attendee rank order lists were collated at the end
of each workshop.
Workshop With Healthcare Professionals
A deliberative workshop was held for physiotherapists and
technical instructors involved in the care of children with CP
in school or community settings. After a short presentation
outlining the findings of the rapid review (Step 1b), attendees
were provided with the short-list of ICF-CY domains and
definitions and asked to rank the domains in order of priority
(1 being highest priority) without referring to others in the
group. The four highest ranked domains were presented back
to the group and time allowed for discussion of the results. The
group were then asked to consider the measurement instruments
(highlighted by the rapid review in Step 1b) associated with
the four highest ranked domains and asked to confirm if they
were aware of the instruments, were they currently available to
them, and had they used them. They were also asked for their
opinions on whether the instrument would be useful in a research
environment and/or clinical practice. The group was also asked
if they were aware of any alternative potential measurement
instruments or technology solutions.
Workshop With Industry
The research team met with industry specialists (designers,
engineers, research and development management, and
therapists involved in manufacture of supportive equipment for
children with CP) to present the findings of the ICF-CY domain
short-listing and rapid review (Steps 1a and 1b). The short-listed
domains were iteratively discussed and industry priorities in
relation to domains of interest were noted.
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TABLE 1 | Short list of domains of interest compiled from ICF-CY core set for CP.
ICF-CY Category Definition
Impairment–body functions
B280 sensation of pain Sensation of unpleasant feeling indicating potential or actual damage to some body structure.
Inclusions: sensations of generalized or localized pain, in one or more body part, pain in a dermatome, stabbing pain,
burning pain, dull pain, aching pain; impairments such as myalgia, analgesia and hyperalgesia.
B440 respiratory functions Functions of inhaling air into the lungs, the exchange of gases between air and blood, and exhaling air.
Inclusions: functions of respiration rate, rhythm and depth; impairments such as apnoea, hyperventilation, irregular
respiration, paradoxical respiration, and brochial spasm, and as in pulmonary emphysema; upper pulmonary obstruction,
reduction in airflow through upper and lower airways.
Exclusions: respiratory muscle functions (b445); additional respiratory functions (b450); exercise tolerance functions (b455).
B455 exercise tolerance functions Functions related to respiratory and cardiovascular capacity as required for enduring physical exertion.
Inclusions: functions of physical endurance, aerobic capacity, stamina, and fatigability.
Exclusions: functions of the cardiovascular system (b410–b429); haematological system functions (b430); respiration
functions (b440); respiratory muscle functions (b445); additional respiratory functions (b450).
B530 weight maintenance functions Functions of maintaining appropriate body weight, including weight gain during the developmental period.
Inclusions: functions of maintenance of acceptable Body Mass Index (BMI); and impairments such as underweight,
cachexia, wasting, overweight, emaciation, and such as in primary and secondary obesity.
Exclusions: assimilation functions (b520); general metabolic functions (b540); endocrine gland functions (b555).
B710 mobility of joint functions Functions of the range and ease of movement of a joint.
Inclusions: functions of mobility of single or several joints, vertebral, shoulder, elbow, wrist, hip, knee, ankle, small joints of
hands, and feet; mobility of joints generalized; impairments such as in hypermobility of joints, frozen joints, frozen shoulder,
arthritis.
Exclusions: stability of joint functions (b715); control of voluntary movement functions (b760).
B730 muscle power functions Functions related to the force generated by the contraction of a muscle or muscle groups.
Inclusions: functions associated with the power of specific muscles and muscle groups, muscles of one limb, one side of
the body, the lower half of the body, all limbs, the trunk and the body as a whole; impairments such as weakness of small
muscles in feet and hands, muscle paresis, muscle paralysis, monoplegia, hemiplegia, paraplegia, quadriplegia, and
akinetic mutism.
Exclusions: functions of structures adjoining the eye (b215); muscle tone functions (b735); muscle endurance functions
(b740).
B7350 muscle tone functions Functions related to the tension present in the resting muscles and the resistance offered when trying to move the muscles
passively.
Inclusions: functions associated with the tension of isolated muscles and muscle groups, muscles of one limb, one side of
the body and the lower half of the body, muscles of all limbs, muscles of the trunk, and all muscles of the body; impairments
such as hypotonia, hypertonia and muscle spasticity, myotonia, and paramyotonia.
Exclusions: muscle power functions (b730); muscle endurance functions (b740).
B740 muscle endurance functions Functions related to sustaining muscle contraction for the required period of time.
Inclusions: functions associated with sustaining muscle contraction for isolated muscles and muscle groups, and all
muscles of the body; impairments such as in myasthenia gravis.
Exclusions: exercise tolerance functions (b455); muscle power functions (b730); muscle tone functions (b735).
B760 control of voluntary movement
functions
Functions associated with control over and coordination of voluntary movements.
Inclusions: functions of control of simple voluntary movements and of complex voluntary movements, coordination of
voluntary movements, supportive functions of arm or leg, right left motor coordination, eye hand coordination, eye foot
coordination; impairments such as control and coordination problems, e.g., clumsiness and dysdiadochokinesia.
Exclusions: muscle power functions (b730); involuntary movement functions (b765); gait pattern functions (b770).
B765 involuntary movement functions Functions of unintentional, non- or semi-purposive involuntary contractions of a muscle or group of muscles.
Inclusions: involuntary contractions of muscles; impairments such as tremors, tics, mannerisms, stereotypies, motor
perseveration, chorea, athetosis, vocal tics, dystonic movements, and dyskinesia.
Exclusions: control of voluntary movement functions (b760); gait pattern functions (b770).
B770 gait pattern functions Functions of movement patterns associated with walking, running, or other whole body movements.
Inclusions: walking patterns and running patterns; impairments such as spastic gait, hemiplegic gait, paraplegic gait,
asymmetric gait, limping, and stiff gait pattern.
Exclusions: muscle power functions (b730); muscle tone functions (b735); control of voluntary movement functions (b760);
involuntary movement functions (b765).
Activity and participation
D410 changing basic body position Getting into and out of a body position and moving from one location to another, such as rolling from one side to the other,
sitting, standing, getting up out of a chair to lie down on a bed, and getting into and out of positions of kneeling or squatting.
Inclusion: changing body position from lying down, from squatting or kneeling, from sitting or standing, bending and shifting
the body’s centre of gravity.
Exclusion: transferring oneself (d420).
(Continued)
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TABLE 1 | Continued
ICF-CY Category Definition
D415 maintaining a body position Staying in the same body position as required, such as remaining seated or remaining standing for work or school.
Inclusions: maintaining a lying, squatting, kneeling, sitting, and standing position.
D420 transferring oneself Moving from one surface to another, such as sliding along a bench or moving from a bed to a chair, without changing body
position.
Inclusions: transferring oneself while sitting or lying.
Exclusion: changing basic body position (d410).
D435 moving objects with lower
extremities
Performing coordinated actions aimed at moving an object by using the legs and feet, such as kicking a ball or pushing
pedals on a bicycle. Inclusions: pushing with lower extremities; kicking.
D450 walking (d4500 walking short
distances)
Moving along a surface on foot, step by step, so that one foot is always on the ground, such as when strolling, sauntering,
walking forwards, backwards, or sideways.
(d4500 = Walking for less than a kilometre, such as walking around rooms or hallways, within a building or for short
distances outside.)
Inclusions: walking short or long distances; walking on different surfaces; walking around obstacles.
Exclusions: transferring oneself (d420); moving around (d455).
D455 moving around Moving the whole body from one place to another by means other than walking, such as climbing over a rock or running
down a street, skipping, scampering, jumping, somersaulting, or running around obstacles.
Inclusions: crawling, climbing, running, jogging, jumping, swimming, scooting, rolling, and shuffling.
Exclusions: transferring oneself (d420); walking (d450).
D460 moving around in different
locations
Walking and moving around in various places and situations, such as walking between rooms in a house, within a building,
or down the street of a town.
Inclusions: moving around within the home, crawling or climbing within the home; walking or moving within buildings other
than the home, and outside the home and other buildings.
D465 moving around using
equipment
Moving the whole body from place to place, on any surface or space, by using specific devices designed to facilitate
moving or create other ways of moving around, such as with skates, skis, scuba equipment, swim fins, or moving down the
street in a wheelchair or a walker.
Exclusions: transferring oneself (d420); walking (d450); moving around (d455); using transportation (d470); driving (d475).
Environment and personal
e115 products and technology for
personal use in daily living
Equipment, products and technologies used by people in daily activities, including those adapted or specially designed,
located in, on or near the person using them.
Inclusions: general and assistive products and technology for personal use.
Exclusions: products and technology for personal indoor and outdoor mobility and transportation (e120); products and
technology for communication (e125).
e120 products and technology for
personal indoor and outdoor mobility
and transportation
Equipment, products and technologies used by people in activities of moving inside and outside buildings, including those
adapted or specially designed, located in, on or near the person using them.
Inclusions: general and assistive products and technology for personal indoor and outdoor mobility and transportation.
e140 products and technology for
culture, recreation and sport
Equipment, products and technology used for the conduct and enhancement of cultural, recreational and sporting
activities, including those adapted or specially designed.
Inclusions: general and assistive products and technology for culture, recreation and sport.
Exclusion: products and technology for play (e1152).
Additional
Health related quality of life Health-related quality of life (HRQoL) is a multi-dimensional concept that includes domains related to physical, mental,
emotional, and social functioning. It goes beyond direct measures of population health, life expectancy, and causes of
death, and focuses on the impact health status has on quality of life.
NB A related concept of HRQoL is well-being, which assesses the positive aspects of a person’s life, such as positive
emotions and life satisfaction.
See also Karimi and Brazier 2016: https://link.springer.com/article/10.1007%2Fs40273-016-0389-9.
Self-concept An idea of the self, constructed from the beliefs one holds about oneself and the responses of others; confidence in one’s
own worth or abilities; self-respect.
Perceptions of effort/ease of
caregiving
Level of difficulty in assisting child to perform self-care activities safely and fulfil the child’s physical needs in a confident and
competent manner within reasonable expectations/Caregiver’s perception of burden of care.
1d. Comparison and Agreement of User
Requirements
The four highest ranked domains from the family and healthcare
profession stakeholder groups were compared and integrated
with the findings from the industry workshop. Final domains
of interest across stakeholder groups were agreed within the
research team. Workshop attendees were provided with a
written summary of findings and the opportunity to provide
further feedback.
Step 2: Device Search
The prioritised domains from Step 1were systematically mapped
to feasible sensor technological solutions based on the process
proposed by Caulfield et al. (12). To achieve this, two researchers
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independently searched online using key terms related to each
domain. Initially, researchers sought to identify technology-
based solutions based on the following criteria:
i) is the system commercially available,
ii) is the solution portable and could it be used in a
community setting,
iii) does the system allow for integration i.e., access to data in
its rawest form/access to the device through an application
programming interface (API) or software development kit
(SDK), and
iv) has the device been used with children with CP or other
movement disorders.
Whilst non-contact wireless solutions show promise in
monitoring of vital signs, they currently suffer from a number of
technical challenges limiting their use in clinical and community
settings. That, coupled with a lack of a commercially available
solution meant that they were not considered for inclusion
in the Digital Toolkit. Further, for domains that could not be
mapped to objective technology-based solutions (e.g., health-
related quality of life), the team identified alternative validated
tools, such as questionnaires, that could be used to capture
these elements.
Step 3: Device Evaluation
Once relevant solutions were identified, researchers undertook
a detailed technical evaluation to ensure the technologies
could be successfully integrated. Criteria for consideration
were based on a combination of those proposed by Caulfield
et al. (12) and Booth et al. (16) and are presented in
Supplementary Material. The technical evaluation expanded on
the criteria specified above (Step 2, Device Selection) to further
refine the selection process. Additional information assessed
at this device evaluation step included device dimensions,
sensors included, battery life, connectivity requirements and data
access, as well as the availability of established software for
data collection and interpretation. The team also investigated
developer support for integration such as the availability of
an SDK or API. Information on regulatory compliance and
scientific evidence, specifically, if the device had been clinically
validated and if it had been used in a CP or paediatric
population was sought. Additionally, purchase information
such as device availability in the target country, cost, and
the availability of technical support was determined. Finally,
human factors such as comfort and usability, as well as
the availability of sizes suitable for a paediatric population,
were considered. Essentially, we sought to identify established
commercial systems that had been validated in the population
and setting of interest, that allowed integration and had
established software for analysis. Researchers searched online
repositories (IEEE Explore, Web of Science and Google
Scholar) for device names along with search terms such as
“children,” “youth,” “paediatric,” and “cerebral palsy” to identify
validation studies and studies reporting use of the with the
target population.
RESULTS
Step 1: Define User Requirements
1a. Identification of Potential Domains of Interest
Eleven impairment and eight activity domains that were likely
to be amenable to change through use of a mobility device
were shortlisted by the research team (Table 1). Three additional
domains were also identified that are not included in the ICF-
CY Core Set for CP but would potentially be amenable to change
through use of amobility device: health related quality of life, self-
concept, and ease of care-giving. Whilst these domains are not
included in the ICF-CY or core sets, they are referred to within
the ICF-CY section “future directions for ICF.”
1b. Rapid Review
No sensor-based technological measurement solutions were
identified from the literature retrieved. For example, the ICF-CY
domain “B455 Exercise Tolerance Functions” mapped to various
“low-tech” solutions such as timed walk tests (1 minute walk test,
2 minute walk test, 6 minute walk test), set-distance walking test
(10mwalk test), shuttle tests (10m shuttle test, 10× 5 sprint test)
and “high-tech” laboratory tests using online gas analysis.
1c. User Engagement
Workshops With Children and Families
Sixteen families responded to the initial advert, however, due
to family and work commitments nine families were unable to
attend the scheduled workshops. Seven families (nine adults in
total) thus attended one of two scheduled family workshops. In
total three grandparents and six parents of children ranging in
age from <2 to 15 years attended. Four children also attended
with their families. Mean score and rank for each domain is
presented in Table 2. Of the 11 short-listed ICF-CY impairment
(body function) domains, families ranked the following as most
important: (1) muscle tone functions, (2) sensation of pain, (3)
mobility of joint functions, and (4) muscle power functions. Of
the eight short-listed ICF-CY activity and participation domains,
families ranked (1) maintaining a body position, (2) moving
around using equipment, (3) walking (short distances), and (4)
moving objects with lower extremities as the most important. In
addition, the groups unanimously agreed that it was important to
consider health-related quality of life, self-esteem and ease of care
when evaluating movement in children with CP.
Workshop With Healthcare Professionals
Fourteen clinicians with a wide range of experience were
present at the workshop (11 physiotherapists and three technical
instructors). The following four ICF-CY impairment (body
function) domains, of the eleven short-listed, were ranked as
most important by clinicians: (1) exercise tolerance functions,
(2) mobility of joint functions, (3) sensation of pain, (4) control
of voluntary movement functions. The top ranked ICF-CY
activity and participation domains, of the eight short-listed,
were: (1) changing basic body position, (2) moving around
using equipment, (3) transferring oneself, and in joint fourth,
moving around, and moving around in different locations. All
healthcare professionals agreed that it was important to consider
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TABLE 2 | Results of workshops.
Family workshops Clinician workshop
Mean score Rank Mean score Rank
Impairment–body functions
Sensation of pain 4.11 2 4.57 3
Respiratory functions 8.38 10 6.29 8
Exercise tolerance functions 7.22 9 3.71 1
Weight maintenance functions 9.89 11 10.21 11
Mobility of joint functions 4.33 3 4.14 2
Muscle power functions 4.78 4 5.36 5
Muscle tone functions 2.56 1 5.93 7
Muscle endurance functions 5.56 6 6.71 9
Control of voluntary movement functions 5.22 5 5.21 4
Involuntary movement functions 7.11 8 8.57 10
Gait pattern functions 6.56 7 5.54 6
Activity and participation
Changing basic body position 4.50 5 2.00 1
Maintaining a body position 3.44 1 4.92 6
Transferring oneself 6.38 8 4.00 3
Moving objects with lower extremities 4.44 4 7.08 8
Walking (short distances) 4.00 3 5.31 7
Moving around 4.56 6 4.46 4
Moving around in different locations 4.56 6 4.46 4
Moving around using equipment 3.38 2 3.69 2
Highlighted cells = Ranked in top 4.
health-related quality of life, self-esteem and ease of care when
evaluating movement in children with CP.
With regards to knowledge and use of measurement
instruments related to the top ranked ICF-CY impairment (body
function) domains, healthcare professionals were most familiar
with the 6 minute walk test (exercise tolerance), goniometry
(mobility of joint) and visual analogue scales (pain). The group
considered that these instruments were useful in both clinical and
research settings.
For measurement of control of voluntary movement, a small
number of healthcare professionals had an appreciation of
laboratory-based measurements such as electromyography and
kinematic measures, however, use of these in their area was
limited. Instead, a subjective description of control of voluntary
movement was reported to be the norm in clinical practice in
community healthcare settings.
No additional instruments or sensor-based technological
solutions were suggested for any of the domains identified
as important.
Workshop With Industry
A workshop was held with four industry specialists working in a
commercial enterprise concerned with design and manufacture
of mobility device products. Professional backgrounds of
participants were therapy, biomedical engineering and research
and development. The priorities of the industry workshop
participants were primarily focused on physiological measures
aligned with the ICF-CY impairment level, such as discerning
muscle activation patterns and ascertaining the “smoothness” of
movement. No additional domains of interest were identified by
industry specialists.
1d. Comparison and Agreement of User
Requirements
The engagement process identified similarities and differences
between groups of stakeholders regarding domains they
considered important to measure. Two top-ranked ICF-CY
impairment domains were common to both families and
clinicians: mobility of joint functions and sensation of pain.
Families’ top-ranked ICF-CY impairment domain was muscle
tone, which was ranked 7th (of 11) by clinicians, whereas,
clinicians’ top-ranked domain was exercise tolerance, which
families ranked 9th (of 11). Differences in perceived priorities
for measurement between families and clinicians were also
evident for the ICF-CY activity and participation domains,
as shown in Table 2: only “moving around using equipment”
was common to both respondent groups. Strong agreement
between clinicians and families was evident in relation to the
importance of health-related quality of life, ease of care, and
self-concept. Domains rated least important were broadly
consistent between stakeholder groups and included weight
maintenance, respiratory function, and involuntary movements.
These domains were thus removed from subsequent steps
in the development of the Digital Toolkit given their lower
perceived importance.
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A high-level summary of findings was communicated directly
to all workshop attendees and circulated via the Northern Ireland
Cerebral Palsy Community Mailing List to disseminate the
findings of the workshops to the wider community. No further
feedback or suggestions were received.
Step 2: Device Search
The research team successfully mapped the prioritised clinical
domains in Step 1 (mobility of joint functions, muscle
tone, muscle power, control of voluntary movement, exercise
tolerance, and moving around using equipment), to potential
instrumented measurements (Table 3), with the exception of
the “sensation of pain” domain. Instrumented techniques
commonly used to measure joint mobility, voluntary movement,
muscle tone, muscle power and moving around, included three
dimensional (3D) motion capture and surface electromyography
(sEMG) (24). Methods to measure exercise tolerance included
vital sign monitors for heart rate (HR) and respiration rate
(RR) (23).
With the underlying instrumented measurements identified,
the research team then began to search for suitable sensor
technologies that met the requirements highlighted previously in
Step 2 of the Methods Section. Findings, by ICF-CY domain, are
summarised below.
Exercise Tolerance
Wearable vital signsmonitors have become increasingly common
and accessible in recent years. Many commercial fitness and
lifestyle monitors, such as Fitbit and Apple Watch, are now
capable of recording information on a user’s heart rate and
activity. The research team chose to focus on chest worn vital
signs monitors rather than wrist or patch-based monitors for
two reasons. Firstly, heart rate measurements from chest strap-
based monitors have been shown to be more accurate compared
to optical wrist-based monitors (29). Secondly, a chest strap was
deemed more practical for participants, particularly considering
the locations of other sensors that the participant would be
required to wear during the study. Chest based monitors come
in two main formats, chest straps or garment integrated (30).
Joint Mobility and Moving Around
The device search identified motion capture (MoCap) as a useful
tool for objectively quantifying human movement. It is often
used with individuals with CP in a clinical or laboratory setting
to analyse walking patterns (31). However, whilst optical based
MoCap is considered the gold standard, most optical MoCap
systems are costly, cumbersome, suffer from optical occlusion,
and require a dedicated laboratory (31). More recently wearable
MoCap systems based on inertial measurement unit (IMU) have
come onto the market. These systems employ sensors fusion and
provide information on degrees of freedom, force, and moment
to estimate joint moments and powers.
Muscle Power, Muscle Tone, and Control of Voluntary
Movement
Surface electromyography (sEMG) was identified as a non-
invasive means of investigating and evaluating skeletal muscle
activity. Contemporary sEMG systems consist of wireless
solutions and generally come in garment-based or fully wireless
sensor forms, thus meet our “portability” requirement (32).
Garment-based solutions tend to focus on specific areas rather
than targeted muscles and are aimed more at consumers rather
than clinical research markets. A number of systems that have
been used in clinical research were identified. These solutions
allow for real-time feedback and can be used outside of a
laboratory setting. Many of these solutions also incorporated
IMU affording the potential for kinematic data capture in tandem
with sEMG. Whilst typically more accurate, the clinical systems
were considerably more expensive than consumer systems.
Step 3: Device Evaluation
With a range of suitable systems identified from the device
search in Step 2, the research team set out to technically evaluate
each of the devices. Technical information was gleaned from
manufacturer websites, with information on clinical validation
and use of the device in the target population coming from
academic publications. The results of the technical evaluation are
summarised in Supplementary Material. With the explosion of
wearable technologies now available on the market, there was
ample choice of instrumented solutions available for review.
Vital signs monitors typically captured information on heart
rate, respiration rate and activity. Some devices captured
additional clinical information including heart rate variability
and temperature. Devices ranged in price from approximately
£200–£1,000. Battery life for these devices typically lasted at
least 24 h and up to 65 h, depending on the sampling and data
transmission rates. These devices usually communicated over
standard transmission protocols such as Bluetooth and provided
good access to raw data.
EMG solutions were generally the most expensive
instrumented element of the Digital Toolkit. System prices
ranged from £12,000 to £20,000. The price was typically
associated with the substantial number of sensors required to
measure the whole body (typically 16 sensors). Nodes generally
included EMG in combination with other sensors to measure
movement such as IMU. EMG systems were generally wireless,
transmitting data over proprietary data transmission. Battery life
was typically 6–10 h depending on the sampling rate and number
of sensors.
For motion capture systems, there was a wide range of
solutions available, from those that use one or two sensors to
track specific measures of gait, to full body motion capture
solutions that use up to 24 sensor nodes. These solutions
typically incorporated IMU sensors with the option to add other
sensing technologies such as force sensors, EMG, and electro-
goniometers. Depending on the sampling rate and the number of
sensors, battery life lasted between 3 and 18 h. Data was typically
transmitted overWi-Fi or proprietary wireless data transmission.
Traditional camera-based systems were also available. However,
these tended to be less portable, susceptible to occlusion and
limited to a set measurement volume.
Across all three application areas, some of the solutions
identified were targeted more toward consumer markets, rather
than research. These solutions tended to be lower cost, however,
are less likely to have been clinically validated. The most
established market was that of vital signs monitoring. Devices
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TABLE 3 | Mapping of instrumented physiological measures from Step 3.
Clinical domain Underlying instrumented physiological measure Identified measurement solution
Sensation of pain No instrumented method is available to assess Sensation of pain. A number of
self-reported scales exist. A small number of papers have measured response of the
sympathetic system to stimuli by measuring the changes in heart rate (HR), heart rate
variability (HRV), pulse amplitude (PA), and galvanic skin response (GSR). Though,
these are not relevant for the current experimentation (22).
None.
Exercise tolerance functions In submaximal tests, like that which would be undertaken in a clinical setting, minute
walking tests are common. This is due to their easy to administer and inexpensive
nature (23). It has been suggested that in addition to distance covered, a measure of
energy expenditure may be useful in differentiating between physical and physiological
factors. For research studies, variables such metabolic energy (e.g., oxygen
consumption) could be used. In the clinic, however, this is not usually feasible. It has
therefore been recommended that heart rate should be monitored both at rest and
during the walk when using the 6-MWT. Other factors that could be measured include
heartrate variability, Exercise intensity level (% of heart rate reserve), heart rate reserve,
breathing pattern, oxygen and carbon dioxide levels in each breath, work rate.





Muscle power functions Muscle torque and force measures were assessed by force sensors in both lower and
upper extremities (24). For the lower extremities, as investigated in this research,
maximum isometric flexion and extension torques of the knee are generally
measured.
A number of studies have previously reported the relationship between the surface
EMG and muscle force (25, 26). Some authors have concluded that the magnitude of
the EMG signal is directly proportional to muscle strength for isometric and/or
isotonic contractions with constant speed for various muscles. Although, surface
EMG is used to quantify muscle activity, the relationship between force, and surface
EMG during voluntary contractions is not fully understood (27). EMG has been used
to understand differences in muscle activity levels during daily activities between
children with cerebral palsy (28).
Force sensors will not be used within
the current study. EMG will be used
to understand muscle activity.
Muscle tone functions Muscle tone and motor flex is commonly measured using sEMG (24). This is either
used alone or in combination with force sensors or position measures. These
measurements are intended to distinguish between dyskinetic and spastic CP. They
can also be used to determine the relation of muscle tone and motor reflex in
dyskinetic CP and the influence of muscle tone and motor reflex on control of
voluntary movement.
sEMG solutions:
1. Delsys trigno avanti
2. Noraxon ultium
3. Cometa wave
4. BTS engineering freeemg
Control of voluntary
movement functions
Control of voluntary movement is generally assed by analyzing muscle activity
through analysis of sEMG (24). The simultaneously contraction of two or more
muscles around a joint and the relative contribution of muscle activity measured
during a repetitive task are commonly used. This has however only been tested in
small groups and requires further development to be used in a clinical setting.
Mobility of joint functions Position and joint angle measurements are typically performed using 3D motion
tracking. This is sometimes combined with other measures such as electrogoniometry
to assess spatiotemporal and kinematic parameters during different tasks (24).
Full body motion capture:
1. Xsens, MTx awinda
2. Nueron, perception
3. APDM, The opal
4. Qualisys
5. Vicon
6. GaitUp, Physiolog 5
7. Trivision
in this category were of reasonable cost, all those identified
had been clinically validated and many had been used with the
target population. Motion capture systems are also very well-
established with many solutions commercially available. Whilst
the cost of these systems is still high, particularly for research
focused systems, this is likely due to the technical complexity of
these solutions which incorporate multiple sensors and require
complex algorithms for data processing.
Summary of Results
Through combination of the aforementioned steps, the
multidisciplinary team developed a Digital Toolkit consisting
of IMU/ motion capture (Xsens) to evaluate joint mobility,
ECG and Respiratory Inductive Plethysmography (Hexoskin)
to evaluate exercise tolerance, and surface EMG (DELSYS) to
explore muscle power, control of voluntary movement and
muscle tone (see Figure 1).
Hexoskin was chosen as an exercise tolerance measurement
solution, over other vital signs solutions, as the system met
selection criteria in terms of measurement requirements (ECG,
HR, and RR), interoperability, access to raw data and portability,
and was clinically validated with a paediatric population. The
Zephyr Bio Harness was considered an appropriate alternative.
Nonetheless the Hexoskin was selected due to its lower cost
and garment-based form factor which was deemed more
practical for this particular population by the research team
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FIGURE 1 | Overview of user-prioritised domains of interest and selected sensor technology.
(See Supplementary Material). Delsys was selected as the EMG
solution, potentially capturing data relating to muscle power,
control of voluntary movement and muscle tone, as again
it met all the relevant selection criteria around measurement
requirements, interoperability, access to raw data and portability.
The solution was also clinically validated, medically certified and
used with people with CP. Compared to the other solutions
investigated, Delsys was found to have slightly lower cost and
good availability of software tools (Supplementary Material).
Finally, for joint mobility and movement, Xsens was selected
as the most appropriate solution. Many of the solutions in
this category were targeted at motion capture and were not
clinically validated. Xsens had been used with people with CP
and had a lower price compared to the other solutions evaluated
(Supplementary Material).
Other user-prioritised domains, such as pain, activity and
participation, health-related quality of life, ease of care and self-
concept, could not be mapped to sensor technology. These are
nonetheless important to users and will be captured through
validated questionnaires.
DISCUSSION
The process reported here provides detailed insights to support
decision-making when developing the Digital Toolkit, a sensor-
based solution for evaluating movement in children with CP,
that will be used in future clinical research projects. Through
rapid review of the current evidence base and engagement with
healthcare professionals, children and families, and industry, a
broad range of perspectives were obtained on the domains that
should be considered. This was followed by a systematic selection
and evaluation process for sensor technologies that addressed the
prioritised domains.
Use of pre-identified core outcome sets for CP (19),
further, refined by deliberative workshops with stakeholders,
allowed the research team to quickly identify meaningful
domains of importance for potential inclusion in our Digital
Toolkit, such as sensation of pain, exercise tolerance, joint
mobility, muscle power, muscle tone, and control of voluntary
movement. Interestingly, although families and clinicians had
differing views on the relative importance of a number of
prioritised domains, there was significant agreement between
stakeholders on domains considered to be less important. These
included weight maintenance, respiratory function, involuntary
movement, gait pattern, and muscle endurance. This is perhaps
unsurprising as therapeutic walking devices typically aim to
provide opportunities for upright mobility, weight-bearing
through the legs and changes in posture, as opposed to delivering
exercise at an intensity sufficient to build muscle endurance or
alter respiratory function and weight. Clinicians and families
also agreed that outcomes related to health-related quality of life,
ease of care, and self-concept were important to consider when
evaluating movement related to mobility devices. Although,
these outcomes do not correspond to domains listed in the
ICF-CY core set for CP, they are important to consider when
introducing new devices or interventions in line with family-
centred care principles. Findings from the deliberative workshops
with stakeholders directly informed the subsequent device search
and device evaluation and ensured that the Digital Toolkit will be
useful and relevant to families, clinicians, and industry.
When mapping sensor technologies in Step 2 of the
process reported here, we identified commercially available,
instrumented measures for all the prioritised domains, except for
sensation of pain. In the 2020 updated definition of pain, the
International Association for the Study of Pain acknowledge the
nuances and complexity of pain, and the difficulties in assessment
of this sensory and emotional experience (33). Even though pain
is very common, given that it is a personal experience influenced
to varying degrees by biological, psychological, and social factors,
the lack of sensor-based measurement solutions is not surprising.
Our device search also highlighted that for some domains, such as
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muscle power and control of voluntary movement, instrumented
measures are not yet well-established and remain subject to
ongoing research and validation (24), whereas, devices such as
sEMG andMoCap are usedmore commonly with our population
of interest. A potential challenge with some of the identified
devices was the ability to collect data in “real-world” settings, i.e.,
outside of a laboratory environment.
A key requirement in developing our Digital Toolkit was
portability as in future studies we plan to evaluate the effects
of mobility devices in “real-world” settings, rather than in
a laboratory environment. Wearable technologies, particularly
garment-based solutions, were noted as having huge potential in
the monitoring of movement outside of the laboratory setting.
Garment-based solutions which incorporate textile electrodes are
available for vital signs monitoring and EMG. Benefits include
comfort (over the application and removal of traditional adhesive
sensors). However, incorporating sensors within a garment
also raises challenges for researchers in relation to the need
for multiple sizes (particularly when working with children),
cleaning regimens, and loss of precision in sensor placement.
The issue of sizing was also apparent in vital signs monitoring
devices, such as chest straps, with few paediatric sized products
being available, especially for younger children.
Variation in measurement precision was noted when
evaluating various vital signs monitors, EMG systems and 3D
motion capture systems. Typically, devices could be categorised
as (1) research/clinical grade, or (2) consumer grade solutions.
For example, for sEMG, full body solutions such as Delsys have
been clinically validated and used in a range of populations in a
research setting, whereas, the more “consumer grade” Myontec
Mbody 3 EMG shorts do not appear to be clinically validated.
A similar situation was identified for 3D motion capture when
comparing the Xsens Awinda system to the lower cost Shadow
MoCap. Whilst these consumer grade systems are less costly
(i.e., ∼£12,000 for Xsens vs. £900 for Myontec) it is difficult to
accurately compare data quality and precision without a formal
validation study. Given that our Digital Toolkit will be used with
children with CP, where changes in outcome measurements can
be small yet clinically meaningful, we selected only solutions
which had been clinically validated or used extensively in
research as specified in our Device Evaluation selection criteria
(Methods, Step 3).
From an interoperability perspective many of the devices were
found to have either an SDK or API. This allows good access
to data in its rawest form whilst also allowing for integration
of multiple systems. Integration and synchronisation will be one
of the key technical challenges with data processing associated
with our Digital Toolkit as it will necessitate combination
of data from a number of systems that have different data
transmission rates, protocols and data formats. Therefore, when
selecting the final set of devices for inclusion in the Digital
Toolkit, it was important to consider them together as a system.
Selecting a research platform like Shimmer, which provides a
number of add on boards to collect a range of physiological
and kinematic parameters such as ECG and EMG, may provide
flexibility to create a bespoke integrated solution on a single
platform. Doing so may, however, have a disadvantage in that
technical development and software tools that have already been
developed and validated through extensive research cannot be
used. Therefore, the research team decided to select established
commercial systems (Methods, Step 2, Device Selection) that
had been validated and provided established software for analysis
(Methods, Step 3, Device Evaluation).
Review of the device evaluation matrix and consideration of
the practicalities of use, measurement precision, interoperability
and cost of the various devices, facilitated selection of a final
set of sensors for inclusion in the Digital Toolkit that met
the priorities of families, clinicians and industry partners.
These included the Hexoskin Classic Pro shirt for vital signs
monitoring, the Delsys Avanti Trigno for EMG and the Xsens
MTw Awinda for 3D motion capture. Combination of these
three solutions provide instrumented measures covering all the
clinical domains of interest. These products also allowed for
integration and synchronisation and were flexible enough to
be configured to measure the muscle groups and movements
required when evaluating mobility devices. Furthermore, the
sensors are wireless, comfortable and can be used outside of
a laboratory setting. All the solutions selected have also been
clinically validated and used in a paediatric population.
Reflections and Critical Perspective
Comparison to Other Frameworks
To the authors’ knowledge, this is the first reported use of
previously published frameworks by Booth et al. (16) and
Caulfield et al. (12) in the selection and evaluation of sensor
technologies for ambulatory human physiological measurement.
The work presented combines the criteria for device selection
and evaluation from both frameworks and expands upon the
frameworks in relation to end-user involvement. The framework
presented by Booth et al. (16) assumes that measurement
domains have been decided upon and that the research team has
performed a device search. It focuses on selecting and managing
sensor technology within a research study. The framework
presented by Caulfield provides considerations for the device
search and criteria for selection of devices, however, the user
involvement is limited, and the focus is mainly on technical
and human factors (12). A summary of the user involvement
in the current study, as per the GRIPP2, is reported in Table 4.
The workflow presented in the current report is summarised in
Table 5, which also compares items between the frameworks. In
relation to defining requirements, the current work expands on
the previous frameworks by increasing the focus on identification
of the priorities for measurement through engagement with
end users.
Strengths
The multidisciplinary approach utilised throughout the
described process was integral for developing a common sense of
purpose within the team. Both clinical researchers and computer
scientists met regularly to discuss and prioritise tasks, share
work in-progress and were involved in decision-making steps.
Co-facilitation of the deliberative workshops with end users
ensured that all members of the team shared a common vision
and language with families and healthcare professionals.
Workshops were tailored according to the stakeholder
group. For example, in the healthcare professional workshop,
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TABLE 4 | GRIPP2 short form.
Item Application in current study
1: Aim
Report the aim of PPI in the study.
• To obtain a broad range of perspectives from end-users on the relative importance of the short-listed domains of interest
for potential inclusion in a Digital Toolkit.
2: Methods
Provide a clear description of the
methods used for PPI in the study.
• ICF-CY domains and their associated definitions, as identified through rapid review, were presented in separate workshops
to three stakeholder groups: (i) children with cerebral palsy and their families; (ii) clinicians; and (iii) industry.
• The workshops were facilitated by both the clinical and computer science researchers.
• A high-level summary of findings was communicated directly to all workshop attendees and circulated via the Northern
Ireland Cerebral Palsy Community Mailing List to disseminate the findings to the wider community.
3: Study results
Outcomes – Report the results of the
PPI in the study, including both
positive and negative outcomes.
• Similarities and differences were identified between groups of stakeholders regarding domains they considered important
to measure.
• Domains common to both families and clinicians were mobility of joint functions and sensation of pain.
• Families’ top-ranked domain was muscle tone [ranked 7th (of 11) by clinicians].
• Clinicians’ top-ranked domain was exercise tolerance [ranked 9th (of 11) by families].
• With regards activity, only “moving around using equipment” was common to both respondent groups.
• Strong agreement between clinicians and families was evident in relation to the importance of health-related quality of life,
ease of care, and self-concept.
• Domains rated least important were broadly consistent between stakeholder groups (and thus removed from subsequent
steps).
• No further feedback was received from attendees or the wider community in response to disseminated results.
4: Discussion and conclusions
Outcomes – Comment on the extent
to which PPI influenced the study
overall. Describe positive and
negative effects.
• The process identified meaningful domains of importance for potential inclusion in our Digital Toolkit.
• Findings from the user engagement workshops directly informed the subsequent device search and device evaluation
and ensured that the Digital Toolkit will be useful and relevant to families and clinicians.
5: Reflections/critical perspective
Comment critically on the study,
reflecting on the things that went well
and those that did not, so others can
learn from this experience.
Strengths
• Co-facilitation of the user engagement workshops ensured that all members of the team shared a common vision and
language with families and healthcare professionals.
• Workshops methods were tailored according to the stakeholder group.
Limitations
• Some families were unable to attend workshops due to work and family commitments.
• Further engagement after the communication of the results could have been used to confirm the domains of interest.
PPI, patient and public involvement.
TABLE 5 | Comparison of frameworks.
Booth et al. (16) Caulfield et al.
(12)
Current report Planned work
Requirements definition Identification of potential domains of interest X
Rapid review of currently used outcome measures X
User engagement to refine domains of interest X
Observation of user in scenario in which sensors are
intended to be used
X
Consideration of human and technical factors X X
Device search Mapping of domains of interest to potential sensors X X
Device evaluation Evaluation and selection of sensors X X X
individuals were asked to consider their responses independently
to avoid deferential effects and inhibition of responses within
a group of mixed seniority, whereas, the patient and family
workshops took a more informal and collaborative approach
in which discussion was encouraged (34). This allowed the
research team to gain more insight into the differing perspectives
within the group. The rapid review and user engagement
methods described expand on the processes described by
Caulfield et al. (12) and Booth et al. (16) which have a greater
focus on the later phases of device selection and evaluation
(see Table 5).
Limitations
Rapid reviews have the advantage of being time efficient
however they have some inherent limitations in comparison to a
systematic review process. In the case of this report, one reviewer
performed study selection and data extraction, and older articles,
non-English articles and grey literature were not considered.
With respect to the deliberative workshops, many families
showed an interest and motivation to engage. However, despite
having various time slots available, some families were unable to
attend due to work and family commitments. This would suggest
that creative strategies to involve families and individuals with
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CP would be of benefit. Strategies that do not involve travel, that
remove the need to arrange time away from work, or the need to
arrange childcare may open opportunities to others.
Further, user engagement after the communication of the
results of the workshops could have been used to confirm
the domains of interest. However, by including all four top
ranked domains from both the family and healthcare professional
workshops it is likely that most user requirements have
been captured.
From a technical perspective, the sensors selected incur
a substantial purchasing cost with the estimated total price
exceeding £25,000.Whilst this represents a significant outlay, and
may preclude roll out of the Digital Toolkit in routine clinical
practice, it is hoped that findings from development of the Digital
Toolkit and collection and interpretation of data will inform
future research directions such as investigation of a minimum set
of sensors that can be utilised and development of a lower cost
solution for longitudinal monitoring in a community setting.
Finally, in relation to scope of purpose, the development of
the Digital Toolkit was focussed on how best to assess the effect
of mobility devices in children with CP. If the scope of purpose
were to be expanded, e.g., to other rehabilitative and assistive
devices, repetition of all three steps in the reported process should
be undertaken.
Future Work
Further evaluation of the Digital Toolkit is planned. Future work
will focus on feasibility of measuring the chosen domains with
the selected sensor technologies in a group of children with CP.
In brief, the objectives will be to assess fidelity and safety of testing
procedures, to record any technical issues with the sensors, to
explore the sensors’ ability to discern between two movement
tasks, and to use qualitative methods to gain an understanding
of the perceptions and preferences of children and families with
CP in relation to the sensor technologies employed.
CONCLUSION
This report demonstrates a systematic approach to user
engagement, and device selection and evaluation, during the
development of a sensor-based solution to a healthcare problem,
building on previous frameworks. It also provides a narrative
on the benefits of employing a multidisciplinary approach
throughout the process. The approach resulted in the selection
of valid, reliable, commercially available, interoperable sensors
that address the priorities of families, healthcare professionals,
industry partners, and academic researchers when evaluating the
effects of mobility devices on movement of children with CP.
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